| Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants J Amer, H Ghoti, E Rachmilewitz, A Koren, C Levin, E Fibach British journal of haematology 132 (1), 108-113, 2006 | 305 | 2006 |
| Urinary tract infection: is there a need for routine renal ultrasonography? G Zamir, W Sakran, Y Horowitz, A Koren, D Miron Archives of disease in childhood 89 (5), 466-468, 2004 | 190 | 2004 |
| Pulmonary hypertension in patients with thalassemia major ZD Du, N Roguin, E Milgram, K Saab, A Koren American heart journal 134 (3), 532-537, 1997 | 169 | 1997 |
| Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1 O Dgany, N Avidan, J Delaunay, T Krasnov, L Shalmon, H Shalev, ... The American Journal of Human Genetics 71 (6), 1467-1474, 2002 | 165 | 2002 |
| Procalcitonin as a marker of acute pyelonephritis in infants and children V Smolkin, A Koren, R Raz, R Colodner, W Sakran, R Halevy Pediatric nephrology 17, 409-412, 2002 | 145 | 2002 |
| Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis Y Butbul-Aviel, A Koren, R Halevy, W Sakran Pediatric emergency care 21 (12), 828-832, 2005 | 137 | 2005 |
| Renal function in children with β-thalassemia major and thalassemia intermedia V Smolkin, R Halevy, C Levin, M Mines, W Sakran, K Ilia, A Koren Pediatric nephrology 23, 1847-1851, 2008 | 111 | 2008 |
| Paediatric cerebral sinus vein thrombosis G Kenet, D Waldman, A Lubetsky, N Kornbrut, A Khalil, A Koren, ... Thrombosis and haemostasis 92 (10), 713-718, 2004 | 104 | 2004 |
| Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera O Weizer‐Stern, K Adamsky, N Amariglio, C Levin, A Koren, W Breuer, ... British Journal of Haematology 135 (1), 129-138, 2006 | 96 | 2006 |
| Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry H Tamary, D Nishri, J Yacobovich, R Zilber, O Dgany, T Krasnov, S Aviner, ... haematologica 95 (8), 1300, 2010 | 87 | 2010 |
| Response to hydroxyurea therapy in β‐thalassemia A Koren, C Levin, O Dgany, T Kransnov, R Elhasid, L Zalman, H Palmor, ... American journal of hematology 83 (5), 366-370, 2008 | 83 | 2008 |
| Prevention of β thalassemia in Northern Israel-a cost-benefit analysis A Koren, L Profeta, L Zalman, H Palmor, C Levin, RB Zamir, S Shalev, ... Mediterranean journal of hematology and infectious diseases 6 (1), 2014 | 77 | 2014 |
| Diversity of β-globin mutations in Israeli ethnic groups reflects recent historic events D Filon, V Oron, S Krichevski, A Shaag, Y Shaag, TC Warren, A Goldfarb, ... American journal of human genetics 54 (5), 836, 1994 | 72 | 1994 |
| Hypocholesterolemia in children and adolescents with β-thalassemia intermedia C Hartman, H Tamary, A Tamir, E Shabad, C Levine, A Koren, R Shamir The Journal of pediatrics 141 (4), 543-547, 2002 | 67 | 2002 |
| Power Doppler ultrasonography in the diagnosis of acute childhood pyelonephritis R Halevy, V Smolkin, S Bykov, L Chervinsky, W Sakran, A Koren Pediatric Nephrology 19, 987-991, 2004 | 66 | 2004 |
| Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small‐platelet thrombocytopenia C Levin, A Koren, E Pretorius, N Rosenberg, B Shenkman, H Hauschner, ... Journal of Thrombosis and Haemostasis 13 (7), 1285-1292, 2015 | 65 | 2015 |
| Detection of β-thalassemia carriers by red cell parameters obtained from automatic counters using mathematical formulas IL Roth, B Lachover, G Koren, C Levin, L Zalman, A Koren Mediterranean journal of hematology and infectious diseases 10 (1), 2018 | 63 | 2018 |
| The incidence of anemia in an Israeli population: a population analysis for anemia in 34512 Israeli infants aged 9 to 18 months J Meyerovitch, M Sherf, F Antebi, M Barhoum-Noufi, Z Horev, L Jaber, ... Pediatrics 118 (4), e1055-e1060, 2006 | 62 | 2006 |
| Non‐transferrin bound labile plasma iron and iron overload in Sickle Cell Disease: a comparative study between Sickle Cell Disease and β thalassemic patients A Koren, D Fink, O Admoni, Y Tennenbaum‐Rakover, C Levin European Journal of Haematology 84 (1), 72-78, 2010 | 61 | 2010 |
| STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds S Nabhani, C Schipp, H Miskin, C Levin, S Postovsky, T Dujovny, A Koren, ... Clinical Immunology 181, 32-42, 2017 | 60 | 2017 |
Carina Levin M.D., Ph.D.Emek Medical Center and Rappaport Faculty of Medicine, Technion, Haifa, IsraelVerified email at clalit.org.il
